These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6661469)

  • 1. 3H-imipramine platelet binding sites in unipolar depression.
    Baron M; Barkai A; Gruen R; Kowalik S; Quitkin F
    Biol Psychiatry; 1983 Dec; 18(12):1403-9. PubMed ID: 6661469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
    Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
    Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet 3H-imipramine binding and response to minaprine in patients with major depression.
    Maj M; Mastronardi P; Palomba U; Romano M; Ventra C; Kemali D
    Pharmacopsychiatry; 1988 Mar; 21(2):101-3. PubMed ID: 3393597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet [3H]imipramine binding in affective disorders: trait versus state characteristics.
    Baron M; Barkai A; Gruen R; Peselow E; Fieve RR; Quitkin F
    Am J Psychiatry; 1986 Jun; 143(6):711-7. PubMed ID: 3717391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
    Faludi G; Tekes K; Tóthfalusi L
    J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity 3H-imipramine binding: a new biological marker in depression.
    Langer SZ; Zarifian E; Briley M; Raisman R; Sechter D
    Pharmacopsychiatria; 1982 Jan; 15(1):4-10. PubMed ID: 7038720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet 3H-imipramine binding: a state-dependent marker in depression.
    Suranyi-Cadotte B; Quirion R; McQuade P; Nair NP; Schwartz G; Mosticyan S; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):737-41. PubMed ID: 6531445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombocyte binding sites for 3H-imipramine in patients with depression].
    Pacáková E
    Cesk Psychiatr; 1989 Oct; 85(5):289-95. PubMed ID: 2624965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in human platelet 3H-imipramine binding.
    Tang SW; Morris JM
    Psychiatry Res; 1985 Oct; 16(2):141-6. PubMed ID: 3865254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet imipramine binding in depressed children and adolescents.
    Ambrosini PJ; Metz C; Arora RC; Lee JC; Kregel L; Meltzer HY
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):298-305. PubMed ID: 1314256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity 3H-imipramine binding in platelets of children and adolescents with major affective disorders.
    Rehavi M; Weizman R; Carel C; Apter A; Tyano S
    Psychiatry Res; 1984 Sep; 13(1):31-9. PubMed ID: 6595683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls.
    Nankai M; Yoshimoto S; Narita K; Takahashi R
    J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of subsensitivity to imipramine in the system of reverse serotonin uptake by thrombocytes in patients with endogenous depression].
    Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Faktor MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(9):96-100. PubMed ID: 3232463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian variation in platelet imipramine binding during the day in healthy subjects.
    Ellis PM; Beeston R; Cooke RR; Mellsop G
    Pharmacopsychiatry; 1991 May; 24(3):76-80. PubMed ID: 1891484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
    Lawrence KM; Falkowski J; Jacobson RR; Horton RW
    Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of membrane protein concentration on binding of 3H-imipramine in human platelets.
    Barkai AI; Kowalik S; Baron M
    Biol Psychiatry; 1985 Feb; 20(2):215-9. PubMed ID: 3971002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
    Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
    J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.